Brown Advisory’s Bio-Rad Laboratories Class A BIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $224K | Sell |
|
|||||
|
2025
Q1 | $264K | Sell |
|
|||||
|
2024
Q4 | $469K | Sell |
|
|||||
|
2024
Q3 | $769K | Sell |
|
|||||
|
2024
Q2 | $961K | Sell |
|
|||||
|
2024
Q1 | $5.69M | Buy |
|
|||||
|
2023
Q4 | $5.03M | Sell |
|
|||||
|
2023
Q3 | $343M | Buy |
|
|||||
|
2023
Q2 | $351M | Buy |
|
|||||
|
2023
Q1 | $405M | Buy |
|
|||||
|
2022
Q4 | $345M | Buy |
|
|||||
|
2022
Q3 | $324M | Buy |
|
|||||
|
2022
Q2 | $288M | Buy |
|
|||||
|
2022
Q1 | $328M | Buy |
|
|||||
|
2021
Q4 | $408M | Sell |
|
|||||
|
2021
Q3 | $426M | Buy |
|
|||||
|
2021
Q2 | $367M | Buy |
|
|||||
|
2021
Q1 | $304M | Buy |
|
|||||
|
2020
Q4 | $277M | Buy |
|
|||||
|
2020
Q3 | $240M | Buy |
|
|||||
|
2020
Q2 | $187M | Buy |
|
|||||
|
2020
Q1 | $121M | Buy |
|
|||||
|
2019
Q4 | $84.6M | Buy |
|
|||||
|
2019
Q2 | – | Sell |
|
|||||
|
2019
Q1 | $376K | Buy |
|
|||||
|
2018
Q4 | $248K | Buy |
|
|||||
|
2018
Q3 | $291K | Buy |
|
|||||
|
2018
Q2 | $262K | Sell |
|
|||||
|
2018
Q1 | $238K | Buy |
|